Generic version of preventive HIV treatment approved

The U.S. Food and Drug Administration (FDA) approved a generic version of a preventive HIV treatment on Monday. The decision will help improve access to the treatment, widely regarded as a major advance. The authorization covers a generic alternative intended to make medication-based prevention against the virus more accessible.